Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1
Review
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,774 | Dovepress* | 6,774+ | 1,677 | 8,451 | |
Totals | 6,774 | 1,677 | 8,451 | ||
*Since 8 February 2008 +Since July 2016 |
View citations on Google Scholar